Local Paclitaxel Delivery to Prevent Restenosis in Peripheral Arterial Disease
NCT03858764 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2019-03-04
Summary
The purpose of this study is to determine if the addition of a catheter-based local delivery of paclitaxel into the peripheral arterial vessels in patients with peripheral arterial disease (PAD) and subsequent restenosis of the femoropopliteal region would benefit from this type of investigational intervention with a known antiproliferative agent.
Conditions
- Peripheral Arterial Disease
- Restenosis
Sponsors & Collaborators
-
Jane Phillips Medical Center
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-08-31
- Primary Completion
- 2013-08-31
- Completion
- 2013-08-31
More Related Trials
-
Evaluation of Paclitaxel in Patients With CLI and Femoropopliteal Occlusive Disease Treated With DCB Angioplasty
NCT02758847 ·Status: COMPLETED ·Phase: NA
-
Photoablative Atherectomy Followed by a Paclitaxel-Coated Balloon to Inhibit Restenosis in Instent Femoro-popliteal Obstructions
NCT01298947 ·Status: UNKNOWN ·Phase: NA
-
Stellarex DCB Versus Standard Balloon Angioplasty for Treatment of Below-The-Knee (BTK) Arteries
NCT03175744 ·Status: SUSPENDED ·Phase: NA
-
Evaluation of All'InCath in Peripheral Vasculature Percutaneous Transluminal Angioplasty.
NCT05497440 ·Status: WITHDRAWN ·Phase: NA
-
Vascular Effects Through Sirolimus vs. Paclitaxel DCB Implantation
NCT05450042 ·Status: RECRUITING ·Phase: NA
-
Paclitaxel-Coated Versus Uncoated Balloon for Treatment of Below-the-Knee In-Stent-Restenosis
NCT01398033 ·Status: WITHDRAWN ·Phase: PHASE3
-
Paclitaxel-coated Balloon Angioplasty Versus Standard Angioplasty for the Treatment of Stenosis of Arteriovenous Fistula
NCT02753998 ·Status: COMPLETED ·Phase: PHASE3
-
PacLitaxel Eluting Balloon Application In Sfa In Stent Restenosis
NCT01587482 ·Status: COMPLETED
-
The OPC for Optimal Delivery of Paclitaxel for the Prevention of Endovascular Restenosis - Above and Below the Knee
NCT02464501 ·Status: COMPLETED ·Phase: NA
-
Paclitaxel Coated Balloon Catheter for Prevention of Restenosis in Femoropopliteal Arteries
NCT00472472 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Drug Coated Balloons for Prevention of Restenosis
NCT00696956 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
DEFINITIVE AR Two Year Follow-up Extension Study
NCT02363894 ·Status: COMPLETED
-
Tack Optimized Balloon Angioplasty Study of the Tack Endovascular System® in Below the Knee Arteries
NCT02942966 ·Status: COMPLETED ·Phase: NA
-
Tack Optimized Balloon Angioplasty Study of the Tack Endovascular System™ in Femoropoliteal Arteries
NCT02522884 ·Status: COMPLETED ·Phase: NA
-
Real-World Safety Analysis of Paclitaxel Devices Used for the Treatment of Peripheral Arterial Disease
NCT04647643 ·Status: COMPLETED
-
Tack Optimized Balloon Angioplasty Post-Market Study
NCT05361967 ·Status: TERMINATED
-
Atherectomy Followed With a Drug Coated Balloon in the Treatment of Long Femoropopliteal Lesions
NCT05868564 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The COPPER-B Trial
NCT02395744 ·Status: COMPLETED ·Phase: NA
-
Paclitaxel Eluting Stent in Long SFA Obstruction: A Prospective, Randomized Comparison With Bypass Surgery
NCT01450722 ·Status: RECRUITING ·Phase: PHASE3
-
Effectiveness of Paclitaxel-coated Luminor® Balloon Catheter Versus Uncoated Balloon Catheter in the Arteria Femoralis Superficialis
NCT02540018 ·Status: COMPLETED ·Phase: NA
-
Pivotal Trial of a Novel Paclitaxel-Coated Percutaneous Angioplasty Balloon
NCT01858428 ·Status: COMPLETED ·Phase: NA
-
Diamondback in Peripheral Vascular Disease
NCT03455374 ·Status: TERMINATED ·Phase: NA
-
Local Paclitaxel or Balloon Angioplasty Below the Knee
NCT03149913 ·Status: UNKNOWN ·Phase: NA
-
Paclitaxel Balloon Versus Standard Balloon in In-stent Restenoses of the Superficial Femoral Artery (PACUBA I Trial)
NCT01247402 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
STREAMER : STent Restenosis And MEdicaments Release
NCT02835586 ·Status: COMPLETED ·Phase: PHASE3